--2025/Q1-- / 1.492M--
--2024/Q4-- / 2.053M--
Nov 13, 20242024/Q31.788M / 1.649M--
Aug 12, 20242024/Q21.112M / 2.632M--
May 14, 20242024/Q13.411M / 2.305M--
US Stock MarketDetailed Quotes
TSHA Taysha Gene Therapies
- 2.9050
- +0.0150+0.52%
Trading Nov 26 11:19 ET
595.36MMarket Cap4.61P/E (TTM)
2.9900High2.8159Low1.15MVolume2.8500Open2.8900Pre Close3.31MTurnover0.91%Turnover RatioLossP/E (Static)204.94MShares4.320052wk High6.71P/B366.30MFloat Cap1.190052wk Low--Dividend TTM126.09MShs Float33.3500Historical High--Div YieldTTM6.02%Amplitude0.5000Historical Low2.8830Avg Price1Lot Size
Taysha Gene Therapies Key Stats
Taysha Gene Therapies Q3 2024 Earnings Date
Currency：USDNov 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 1.65M | 1.79M | +139.36K |
| Beat Est. | -65.26% | -62.33% | +8.45% |
| EPS | -0.09 | -0.10 | -0.01 |
| Miss Est. | +90.43% | +89.25% | -12.36% |
Analyst Rating
Nov 15, 2024
Taysha Gene Therapies Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Taysha Gene Therapies Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
